EMBC Investment Deadline: Embecta Securities Fraud Class Action Focuses on Insulin Pen Issues; Investors Notified of August 17 Court Deadline

A securities fraud class action lawsuit has been filed on behalf of Embecta investors after its stock plummeted over 57% because Embecta allegedly misled investors regarding the strength of its insulin pen needle product category. NEW YORK, July 7, 2026 /PRNewswire/ -- Leading securities...